A detailed history of Ameriprise Financial Inc transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 11,620 shares of CCCC stock, worth $39,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,620
Holding current value
$39,043
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.43 - $7.38 $51,476 - $85,755
11,620 New
11,620 $66,000
Q3 2023

Nov 14, 2023

SELL
$1.81 - $3.89 $199 - $427
-110 Reduced 0.16%
69,486 $129,000
Q2 2023

Aug 14, 2023

SELL
$2.75 - $3.77 $28,982 - $39,732
-10,539 Reduced 13.15%
69,596 $191,000
Q1 2023

May 15, 2023

BUY
$3.1 - $9.02 $128,609 - $374,212
41,487 Added 107.35%
80,135 $251,000
Q4 2022

Feb 14, 2023

SELL
$5.42 - $10.24 $42,330 - $79,974
-7,810 Reduced 16.81%
38,648 $228,000
Q3 2022

Nov 14, 2022

BUY
$8.03 - $12.77 $373,057 - $593,268
46,458 New
46,458 $407,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $164M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.